Current status and future prospects of drug-coated balloons in the treatment of lower extremity arteriosclerosis obliterans
10.7659/j.issn.1005-6947.2024.12.019
- VernacularTitle:药物涂层球囊在下肢动脉粥样硬化闭塞症治疗中的应用现状与未来展望
- Author:
Bin LIU
1
;
Liang GUI
;
Junjie ZOU
Author Information
1. 南京医科大学第二临床学院,江苏南京 210029
- Publication Type:Journal Article
- Keywords:
Arterial Occlusive Diseases;
Lower Extremity;
Drug-Coated Balloon;
Review
- From:
Chinese Journal of General Surgery
2024;33(12):2091-2098
- CountryChina
- Language:Chinese
-
Abstract:
With the continuous advancement of peripheral vascular interventional techniques and devices,drug-coated balloons (DCBs) have emerged as a promising therapeutic tool,garnering significant attention in endovascular treatment for lower extremity arterial diseases. Lower extremity arteriosclerosis obliterans (LEASO) is the most common type of lower extremity arterial disease and one of the key indications for DCB technology. While DCBs have achieved remarkable progress in treating femoropopliteal lesions,their efficacy in specific lower extremity arterial conditions,such as chronic limb-threatening ischemia and in-stent restenosis,remains controversial and challenging. This article summarizes and analyzes relevant clinical studies to evaluate the application,safety,clinical efficacy,and future directions of DCBs in treating LEASO,providing deeper insights and guidance for clinical practice.
